These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 18990027)

  • 21. Glioblastoma multiforme in patients with history of extracranial cancer: Case series.
    Kalita O; Trojanec R; Megova M; Hajduch M; Vaverka M; Hrabalek L; Zlevorova M; Drabek J; Tuckova L; Vrbkova J
    Clin Neurol Neurosurg; 2016 May; 144():39-43. PubMed ID: 26971293
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era.
    Niranjan A; Kano H; Iyer A; Kondziolka D; Flickinger JC; Lunsford LD
    J Neurosurg; 2015 Apr; 122(4):757-65. PubMed ID: 25594327
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dual-isotope single-photon emission computerized tomography scanning in patients with glioblastoma multiforme: association with patient survival and histopathological characteristics of tumor after high-dose radiotherapy.
    Schwartz RB; Holman BL; Polak JF; Garada BM; Schwartz MS; Folkerth R; Carvalho PA; Loeffler JS; Shrieve DC; Black PM; Alexander E
    J Neurosurg; 1998 Jul; 89(1):60-8. PubMed ID: 9647173
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomized study of postoperative radiotherapy and simultaneous temozolomide without adjuvant chemotherapy for glioblastoma.
    Kocher M; Frommolt P; Borberg SK; Rühl U; Steingräber M; Niewald M; Staar S; Stuschke M; Becker G; Fischedick AR; Herfarth K; Grauthoff H; Müller RP
    Strahlenther Onkol; 2008 Nov; 184(11):572-9. PubMed ID: 19016015
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Temozolomide combined with irradiation as postoperative treatment of primary glioblastoma multiforme. Phase I/II study.
    Combs SE; Gutwein S; Schulz-Ertner D; van Kampen M; Thilmann C; Edler L; Wannenmacher MM; Debus J
    Strahlenther Onkol; 2005 Jun; 181(6):372-7. PubMed ID: 15925979
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current developments in the radiotherapy approach to elderly and frail patients with glioblastoma multiforme.
    Roa W; Xing JZ; Small C; Kortmann R; Miriamanoff R; Okunieff P; Shibamoto Y; Jeremic B
    Expert Rev Anticancer Ther; 2009 Nov; 9(11):1643-50. PubMed ID: 19895247
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pulsed versus conventional radiation therapy in combination with temozolomide in a murine orthotopic model of glioblastoma multiforme.
    Lee DY; Chunta JL; Park SS; Huang J; Martinez AA; Grills IS; Krueger SA; Wilson GD; Marples B
    Int J Radiat Oncol Biol Phys; 2013 Aug; 86(5):978-85. PubMed ID: 23845846
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognosis factors of survival time in patients with glioblastoma multiforme: a multivariate analysis of 340 patients.
    Mineo JF; Bordron A; Baroncini M; Ramirez C; Maurage CA; Blond S; Dam-Hieu P
    Acta Neurochir (Wien); 2007 Mar; 149(3):245-52; discussion 252-3. PubMed ID: 17273889
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neoadjuvant bevacizumab and irinotecan versus bevacizumab and temozolomide followed by concomitant chemoradiotherapy in newly diagnosed glioblastoma multiforme: A randomized phase II study.
    Hofland KF; Hansen S; Sorensen M; Engelholm S; Schultz HP; Muhic A; Grunnet K; Ask A; Costa JC; Kristiansen C; Thomsen C; Poulsen HS; Lassen U
    Acta Oncol; 2014 Jul; 53(7):939-44. PubMed ID: 24456504
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Postoperative treatment of primary glioblastoma multiforme with radiation and concomitant temozolomide in elderly patients.
    Combs SE; Wagner J; Bischof M; Welzel T; Wagner F; Debus J; Schulz-Ertner D
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):987-92. PubMed ID: 17967509
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preservation of quality of life by preradiotherapy stereotactic radiosurgery for unresectable glioblastoma multiforme.
    Kong DS; Nam DH; Lee JI; Park K; Kim JH
    J Neurosurg; 2006 Dec; 105 Suppl():139-43. PubMed ID: 18503347
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of recurrent glioblastoma multiforme with GliaSite brachytherapy.
    Chan TA; Weingart JD; Parisi M; Hughes MA; Olivi A; Borzillary S; Alahakone D; Detorie NA; Wharam MD; Kleinberg L
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1133-9. PubMed ID: 15990019
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metastatic seeding of the stereotactic biopsy tract in glioblastoma multiforme: case report and review of the literature.
    Steinmetz MP; Barnett GH; Kim BS; Chidel MA; Suh JH
    J Neurooncol; 2001 Dec; 55(3):167-71. PubMed ID: 11859971
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CT-guided interstitial HDR brachytherapy for recurrent glioblastoma multiforme. Long-term results.
    Tselis N; Kolotas C; Birn G; Röddiger S; Filipowicz I; Kontova M; Fountzilas G; Selviaridis P; Baltas D; Heyd R; Anagnostopoulos G; Zamboglou N
    Strahlenther Onkol; 2007 Oct; 183(10):563-70. PubMed ID: 17896088
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patterns of failure and comparison of different target volume delineations in patients with glioblastoma treated with conformal radiotherapy plus concomitant and adjuvant temozolomide.
    Minniti G; Amelio D; Amichetti M; Salvati M; Muni R; Bozzao A; Lanzetta G; Scarpino S; Arcella A; Enrici RM
    Radiother Oncol; 2010 Dec; 97(3):377-81. PubMed ID: 20855119
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Afatinib, an irreversible ErbB family blocker, with protracted temozolomide in recurrent glioblastoma: a case report.
    Alshami J; Guiot MC; Owen S; Kavan P; Gibson N; Solca F; Cseh A; Reardon DA; Muanza T
    Oncotarget; 2015 Oct; 6(32):34030-7. PubMed ID: 26423602
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Survival following CyberKnife radiosurgery and hypofractionated radiotherapy for newly diagnosed glioblastoma multiforme.
    Lipani JD; Jackson PS; Soltys SG; Sato K; Adler JR
    Technol Cancer Res Treat; 2008 Jun; 7(3):249-55. PubMed ID: 18473497
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients.
    Brandes AA; Franceschi E; Tosoni A; Blatt V; Pession A; Tallini G; Bertorelle R; Bartolini S; Calbucci F; Andreoli A; Frezza G; Leonardi M; Spagnolli F; Ermani M
    J Clin Oncol; 2008 May; 26(13):2192-7. PubMed ID: 18445844
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Angiogenesis inhibitor DC101 delays growth of intracerebral glioblastoma but induces morbidity when combined with irradiation.
    Verhoeff JJ; Stalpers LJ; Van Noorden CJ; Troost D; Ramkema MD; van Bree C; Song JY; Donker M; Chekenya M; Vandertop WP; Richel DJ; van Furth WR
    Cancer Lett; 2009 Nov; 285(1):39-45. PubMed ID: 19473756
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Temozolomide concomitant and adjuvant to radiotherapy in elderly patients with glioblastoma: correlation with MGMT promoter methylation status.
    Brandes AA; Franceschi E; Tosoni A; Benevento F; Scopece L; Mazzocchi V; Bacci A; Agati R; Calbucci F; Ermani M
    Cancer; 2009 Aug; 115(15):3512-8. PubMed ID: 19514084
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.